Chemotherapy, radiotherapy and immunotherapy for cancer - MBS item (15900)

The following MBS item is included in this clinical category.

15900
BREAST, MALIGNANT TUMOUR, targeted intraoperative radiation therapy, using an Intrabeam®or Xoft® Axxent® device, delivered at the time of breast-conserving surgery (partial mastectomy or lumpectomy) for a patient who: a) is 45 years of age or more; and b) has a T1 or small T2 (less than or equal to 3cm in diameter) primary tumour; and c) has an histologic Grade 1 or 2 tumour; and d) has an oestrogen-receptor positive tumour; and e) has a node negative malignancy; and f) is suitable for wide local excision of a primary invasive ductal carcinoma that was diagnosed as unifocal on conventional examination and imaging; and g) has no contra-indications to breast irradiation Applicable only once per breast per lifetime (H)

Return to Chemotherapy, radiotherapy and immunotherapy for cancer item list